Global Pharmaceuticals & Biotech Big Green Snowflakes

RemeGen

Market Cap: HK$60.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Morepen Laboratories

Market Cap: ₹29.3b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Seelos Therapeutics

Market Cap: US$1.0

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system and other disorders.

Intravenous Infusions

Market Cap: GH₵13.7m

A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

Edesa Biotech

Market Cap: US$17.1m

A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.

Mirum Pharmaceuticals

Market Cap: US$3.9b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Heidelberg Pharma

Market Cap: €165.4m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

Arctic Bioscience

Market Cap: NOK 105.0m

A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.

ExpreS2ion Biotech Holding

Market Cap: SEK 55.4m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

Strategic Partners

Market Cap: DKK 40.1m

Does not have significant operations.

Rallybio

Market Cap: US$24.3m

A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Werewolf Therapeutics

Market Cap: US$62.6m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

Compass Therapeutics

Market Cap: US$597.1m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

MetaVia

Market Cap: US$16.4m

A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.

Klotho Neurosciences

Market Cap: US$33.0m

Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.

Tvardi Therapeutics

Market Cap: US$298.4m

A clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States.

Korro Bio

Market Cap: US$339.2m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Monte Rosa Therapeutics

Market Cap: US$298.3m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

Cyclerion Therapeutics

Market Cap: US$8.3m

A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.

CRISM Therapeutics

Market Cap: UK£3.8m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

Fennec Pharmaceuticals

Market Cap: US$256.6m

Operates as a commercial stage biopharmaceutical company in the United States.

IGC Pharma

Market Cap: US$38.2m

A clinical stage pharmaceutical company, develops treatments for Alzheimer’s disease in the United States and Colombia.

CervoMed

Market Cap: US$92.5m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

Petros Pharmaceuticals

Market Cap: US$1.2m

A healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.

Absci

Market Cap: US$379.8m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

Anebulo Pharmaceuticals

Market Cap: US$90.4m

A clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Gyre Therapeutics

Market Cap: US$696.6m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

Omeros

Market Cap: US$289.9m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

MediPharm Labs

Market Cap: CA$31.6m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Esperion Therapeutics

Market Cap: US$512.1m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

Neumora Therapeutics

Market Cap: US$270.4m

A clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States.

Swedencare

Market Cap: SEK 6.3b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

CNS Pharmaceuticals

Market Cap: US$3.8m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.

Genelux

Market Cap: US$137.0m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Bacil Pharma

Market Cap: ₹502.4m

Manufactures, exports, and retails pharmaceuticals, medicinal chemicals, and botanical products in India.

Fabino Enterprises

Market Cap: ₹54.6m

Manufactures, markets, trades, and packages pharmaceutical and other wellness focused consumer products in India.